Presenter of the TCT 174 presentation on high bleeding risk and outcomes in acute coronary syndrome after percutaneous coronary intervention with versus without cangrelor.[7]
2024
Listed as a current cardiovascular disease fellow in the Class of 2029 at MedStar Health.
As of 2029 · Last known relationship
Patrick Creechan is a cardiovascular medicine trainee whose public record combines clinical training with research on antiplatelet therapy in acute coronary syndrome. He is listed as a current cardiovascular disease fellow in MedStar Health’s Class of 2029. His prior training includes residency at MedStar Washington Hospital Center and medical school at University College Dublin School of Medicine and Medical Science. In 2024, he presented TCT 174, examining outcomes in high-bleeding-risk patients with acute coronary syndrome after percutaneous coronary intervention with versus without cangrelor.
Each topic is linked to its supporting source in Sources.
Training includes Listed as a current cardiovascular disease fellow in the Class of 2029 at MedStar Health., Medical school at University College Dublin School of Medicine and Medical Science., and Residency at MedStar Washington Hospital Center..
Explore education and trainingPresenter of the TCT 174 presentation on high bleeding risk and outcomes in acute coronary syndrome after percutaneous coronary intervention with versus without cangrelor.[7]
2024